Lupin gets USFDA nod for asthmatic symptoms prevention drug

Drug major Lupin on Tuesday said it has received approval from the US health regulator for its Albuterol Sulfate Inhalation Aerosol, used for the treatment of acute episodes of bronchospasm or prevention of asthmatic symptoms. The approved product is a generic version of ProAir HFA of Teva Branded Pharmaceutical Products R&D, Inc.




Read the Rest at INDIA TV

Leave a Reply

Your email address will not be published. Required fields are marked *